Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q3 EPS of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $484.6 million versus the consensus estimate of $475.84 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.